Antitumor activation of peritoneal macrophages by thymosin alpha-1

Cancer Investigation

Volumn 23, Issue 4, 2005, Pages 316-322

  Shrivastava, Pratima ^a   Singh, Sukh Mahendra ^a   Singh, Nisha ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Activation; Adoptive transfer; Macrophages; Thymosin alpha 1; Tumor cells

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 1; NITRIC OXIDE; THYMOSIN ALPHA1; TUMOR NECROSIS FACTOR ALPHA; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; THYMOSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; IMMUNOTHERAPY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; T CELL LYMPHOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REGRESSION; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; IMMUNOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOMA, T-CELL; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; THYMOSIN;

EID: 24744466747     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1081/CNV-58813     Document Type: Article

References (34)

1. Bartholeyns, J. Monocytes and macrophages in cancer immunotherapy. Res. Immunol. 1993, 144, 288.
2. Adam, D.O.; Hamilton, T.A. The cell biology of macrophage activation. Annu. Rev. Immunol. 1984, 2, 283.
3. Muhiradt, P.F.; Kieb, M.; Meyer, H.; Sobmuth, R.; Jung, G. Isolation, structure elucidation and synthesis of a macrophage stimulatory lipopeptide from mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 1997, 185, 1951.
4. Bharti, A.; Singh, S.M. Inhibition of macrophage nitric oxide production by gangliosides derived from a spontaneous T-cell lymphoma: the involved mechanisms. Nitric Oxide 2003, 8, 75-82.
5. Bharti, A.; Singh, S.M. Gangliosides derived from a T cell lymphoma inhibit bone marrow cell proliferation and differentiation. Int. Immunopharmacol. 2001, 1, 155-165.
6. Shanker, A.; Singh, S.M. Immunopotentiation in mice bearing a transplantable T-cell lymphoma: role of thymic extract. Neoplasma 2003, 50, 272-279.
7. Singh, N.; Singh, S.M.; Shrivastava, P. Immunomodulatory and antitumor actions of medicinal plant Tinospora cordifolia are mediated through activation of tumor-associated macrophages. Immunopharmacol. Immunotoxicol. 2004, 26, 145-162.
8. Baumann, C.; Badamchian, M.; Goldestin, A.L. Preclinical studies of thymosinα1 and thymosin β4. In Thymic Peptides in Preclinical and Clinical Medicine and Update; Maurer, H.R., Goldestin, A.L., Hager, E.D., Eds.; W. Zuckschwerdt Verlag: Munchen, 1997; 13-27.
9. Baxevanis, C.N.; Reclos, G.J.; Papamichail, M. Prothymosinα restores depressed allogenic cell mediated lympholysis and natural-killer-cell activity in-patients with cancer. Int. J. Cancer 1993, 53, 264.
10. Beuth, J.; Schierholz, J.M.; Mayer, G. Thymosin alpha-1 application augments immune response and down regulates tumor weight and organ colonization in BALB/c-mice. Cancer Lett. 2000, 159, 9.
11. Bodey, B.; Bodey, B., Jr.; Sigel, S.E.; Kaiser, H.E. Review of thymic hormones in cancer diagnosis and treatment. Int. Immunopharmacol. 2000, 22, 261.
12. Garaci, E.; Pica, F.; Rasi, G.; Favalli, C. Thymosinα1 in the treatment of cancer from basic research to clinical application. Int. J. Immunopharmacol. 2000, 22, 1067.
13. Kullavanuaya, P.; Treeprasertsuk, S.; Thongnngam, B.; Chaermthai, K.; Gonlachanvit, S.; Suwanagool, P. The combined treatment of interferon alpha-2a and thymosinα1 for chronic hepatitis c: the 48 weeks of treatment result. J. Med. Assoc. Thail. 2001, 84, 5462-5468.
14. Ohmori, H.; Kamo, M.; Yamakoshi, K.; Nitta, M.H.; Hikida, M.; Kanayama, N. Restoration of immunocyte function by thymosinα1 in cyclophosphamide induced immunodeficient mice. Immunopharmacol. Immunotoxicol. 2001, 23, 75.
15. Roy, R.; Singh, S.M.; Shanker, A. Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosinα1. Int. J. Immunopharmacol. 2000, 22, 309.
16. Shrivastava, P.; Singh, S.M.; Singh, N. Effect of thymosin alpha1 on nitric oxide production by tumour associated macrophages. Neoplasma 2003, 50, 47-53.
17. Singh, S.M.; Parajuli, P.; Shrivastava, A.; Sodhi, A. Alteration of the immune response by tumor cells: underlying mechanisms. Int. J. Immunopathol. 1997, 10, 27-35.
18. Dijkstra, C.D.; Dop, E.A.; Joling, P.; Karrel, G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophages subpopulation in rat recognized by monoclonal antibodies ED1, ED2, and ED3. Immunology 1985, 51, 477.
19. Gjomarkaj, M.; Pace, E.; Melis, M.; Spatafora, M.; Profita, M.; Vignola, A.M.; Bonsignore, G.; Toews, G.B. Phenotypic and functions characterization of normal rat pleural macrophages in comparison with autologous peritoneal and alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1999, 20, 135.
20. Kumar, A.; Parajuli, P.; Singh, S.M. Modulatory effects of Dalton's lymphoma cells on the production of reactive nitrogen intermediates, IL-1 and TNF by murine peritoneal macrophages. Neoplasma 1994, 44, 363.
21. Parjuali, P.; Singh, S.M. Modulation of hemopoiesis in normal and tumor-bearing mice on in vivo administration of FK565. Int. J. Immunopathol. Pharmacol. 1995, 8, 103.
22. Kumar, A.; Singh, S.M. Effect of tumor growth on the blastogenic response of splenocytes: a role of macrophage derived NO. Immunol. Invest. 1996, 35, 413.
23. Ding, A.H.; Nathan, C.F.; Stuher, D.J. Release of reactive nitrogen and oxygen intermediates from murine peritoneal macrophages: comparison of the activation cytokines and independent production. J. Immunol. 1988, 141, 2407.
24. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 1983, 65, 55.
25. Jalali, A.; Stoklosa, T.; Giermasz, A.; Olszewska, D.; Wilczynski, G.; Jakobisiak, M.; Golab, J. A single injection of immature dendritic cell is able to induce antitumour response against a murine colon adenocarcinoma with a low apoptoic index. Oncol. Rep. 2002, 9, 991-994.
26. Curie, A.D.; Stewart, A.G.; William, A.S. Alveolar macrophages bind and phagocytose allergen containing pollen starch granules via C-type lectin and integrin receptors: implication for airway inflammatory disease. J. Immunol. 2000, 164, 3878.
27. Paul, S.; Sodhi, A.; Biswas, S. Activation of murine BMDM in vitro with thyá1 to tumoricidal state: a comparative study on normal and tumour bearing host. J. Leukoc. Biol. 2001, 70, 163.
28. Parajuli, P.; Singh, S.M.; Kumar, A.; Sodhi, A. Alterations in the tumoricidal functions of murine tumor associated macrophages during progressive growth of tumor in vivo. Cancer J. 1997, 10, 222-228.
29. Otto, B.; Oligive, A. The response of peritoneal macrophages after implantation of several ceramics as measured by change of ectoenzyme activity. Biomaterials 1998, 19, 1049.
30. Garaci, C.; Torrisi, M.R.; Jezzi, T.; Frati, L.; Goldstein, A.L.; Garaci, E. Receptors for thymosinα1 on mouse thymocytes. Cell. Immunol. 1985, 91, 289.
31. Shrivastava, P.; Singh, S.M.; Singh, N. Activation of tumour associated macrophages by thymosin alpha1. Int. J. Immuopathol. Pharmacol. 2004, 77.
32. Millis, C.D.; Kincaid, K.; Alt, J.M.; Heliman, M.J.; Annette, M.H. M1/M2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000, 164, 6166-6173.
33. Kutaza, J.; Fields, K.; Gumm, T.A.; Clouse, K.A. Inhibition of HIV replication and macrophage CSF production in human macrophage by antiretroviral agents. AIDS Res. Hum. Retrovir. 2002, 18, 619.
34. Johannes, S.A.; Caruno, J.A. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. J. Immunol. 1988, 141, 3680.